Antinociceptive effects of an ethanolic extract of Capparis erythrocarpos isert roots in the mice formalin test

International Journal of Pharmacology

Volumn 5, Issue 6, 2009, Pages 354-361

  Woode, E ^a   Danquah, C A ^a   Boakye Gyasi, E ^a   Ansah, C ^a   Ainooson, G ^a   Woode, Eric ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Capparis erythrocarpos; Formalin; Mice; Morphine; Naloxone; Theophylline

Indexed keywords

ANALGESIC AGENT; CAPPARIS ERYTHROCARPOS EXTRACT; FORMALDEHYDE; MORPHINE; NALOXONE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPPARIS; CAPPARIS ERYTHROCARPOS; DRUG EFFICACY; FEMALE; MALE; MOUSE; NERVE STIMULATION; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PHARMACOLOGICAL BLOCKING; PLANT ROOT; SCORING SYSTEM; STIMULUS RESPONSE;

EID: 73449128671     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2009.354.361     Document Type: Article

References (44)

1. Agarwal, R.B. and V.D. Rangari, 2003. Phytochemical investigation and evaluation of anti-inflammatory and anti-arthritic activities of essential oil of Strobilanthus ixiocephala Benth. Indian J. Exp. Biol., 41: 890-894.
2. Ageel, A.M., N. S. Parmar, J.S. Mossa, M.A.A. Yahya, M.S.A. Said and M. Tariq, 1986. Anti-inflammatory activity of some Saudi Arabian medicinal plants. Agents Action, 17: 383-384.
3. Amr, A.G.E. and M.M. Abdulla, 2006. Synthesis and anti-inflammatory activities of new cyanopyrane derivatives fused with steroidal nuclei. Arch Der Pharm., 339: 88-95.
4. Balunas, M.J. and A.D. Kinghorn, 2005. Drug discovery from medicinal plants. Life Sci., 78: 431-441.
5. Bars, D.L., M. Gozarriu and S.W. Gadden, 2001. Animal models of nociception. Pharmacol. Rev., 53: 597-652.
6. Bohn, L.M., R.J. Lefkowitz and M.G. Caron, 2002. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta) arrestin-2 knock-out mice. J. Neurosci., 22: 10494-10500.
7. Braddock, M., 2007. 11th annual inflammatory and immune diseases drug discovery and development summit. Exp. Opin. Invest. Drugs, 16: 909-917.
8. Breuer, G.S., H. Orbach, O. Elkayam, Y. Berkun, D. Paran, M. Mates and G. Nesher, 2006. Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel. Isr. Med. Assoc. J., 8: 184-187.
9. Catherine, G., V. Kayser, J.J.I. Heikkila and G. Guilbaud, 1996. The antinociceptive activity of kappa-but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats. Eur. J. Pharmacol., 318: 273-281.
10. Dickenson, A.H., R. Suzuki and A.J. Reeve, 2000. Adenosine as a potential target in inflammatory and neuropathic pains. CNS Drugs, 13: 77-85.
11. Dubuisson, D. and S.G. Dennis, 1977. The formalin test a quantitave study of the analgesic effects of morphine meperidine and brain stem stimulation in rats and cats. Pain, 4: 161-174.
12. Fredholm, B.B., I. Jzerman, K.A. Jacobson, K.N. Klotz and J. Linden, 2001. International union of pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53: 527-552.
13. Hayashida, K., T. Takeuchi, H. Shimizu, K. Ando and E. Harada, 2003. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. Am. J. Physiol. Regul. Integr. Comp. Physiol., 285: 306-312.
14. Herrero, J.F. and P.M. Headley, 1996. Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID. Br. J. Pharmacol., 118: 968-972.
15. Irvine, F.R., 1961. Woody Plants of Ghana. 1st Edn., Oxford University Press, London.
16. Jarvis, M.F., H. Yu, S. McGaraughty, C.T. Wismer and J. Mikusa et al., 2002. Analgesic and anti-inflammatory effects of A-286501 a novel orally active adenosine kinase inhibitor. Pain, 96: 107-118.
17. Kaplan, M., E.A. Mutlu, M. Benson, J.Z. Fields, A. Banan and A. Keshavarzian, 2007. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther. Med., 15: 207-216.
18. Khurdayan, V. and S. Davies, 2005. Sequences in drug discovery. Drug News, Perspect., 18: 197-201.
19. Kowaluk, E.A., J. Mikusa, C.T. Wismer, C.Z. Zhu and E. Schweitzer et al. 2000. ABT-702 (4-Ammo-5-(3-bromophenyl) -7-(6-morpholino-pyridin-3-yl) pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J. Pharmacol. Exp. Ther., 295: 1165-1174.
20. Lee, M.S., M.S. Lee, C.Y. Yang, S.I. Lee and M.C. Joo et al., 2008. Use of complementary and alternative medicine by rheumatoid arthritis patients in Korea. Clin. Rheumatol., 27: 29-33.
21. Liu, L., E. Buchner, D. Beitze, C.B.S. Weber, V. Kaever, F. Emmrich and R.W. Kinne, 1996. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int. J. Immunopharmacol., 18: 529-543.
22. Malmberg, A.B. and T.L. Yaksh, 1992. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther., 263: 136-146.
23. Mbagwu, H.O.C., R.A. Anene and O.O. Adeyemi, 2007. Analgesic antipyretic and anti-inflammatory properties of Mezoneuron benthamianum Baill (Caesalpiniaceae). Nig. J. Hosp. Med., 17: 35-41.
24. Miller, J.R., 2003. GraphPad Version 4.0. Step-by-Step Examples. 1st Edn., GraphPad Software Inc., San Diego, CA.
25. Motulsky, H.J. and A. Christopoulos, 2003. Fitting Model to Biological Data using Linear and Nonlinear Regression a Practical Guide to Curve Fitting. 1 st Edn., GraphPad Software Inc., San Diego, CA.
26. Mshana, N.R., D.K. Abbiw, I. Addae-Mensah, E. Adjanouhoun and M.R.A. Ahyi et al., 2000. Traditional Medicine and Pharmacopoea contribution to the Revision of Ethnobotanical and Floristic Studies in Ghana. 2nd Edn., Scientific, Technical and Research Commission of the Organization of Africa, Nieria, ISBN: 978-2453-66-2, pp: 137-419, 732-733.
27. Narendhirakannan, R. T., S. Subramanian and M. Kandaswamy, 2007. Anti-inflammatory and lysosomal stability actions of Oleome gynandra L. studied in adjuvant induced arthritic rats. Food Chem. Toxicol., 45: 1001-1012.
28. Poon, A. and J. Sawynok, 1999. Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor. Eur. J. Pharmacol., 384: 123-138.
29. Rajnarayanan, R.V., C.W. Rowley, N.E. Hopkins and W.L. Alworth, 2001. Regulation of phenobarbital-mediated induction of CYP102 (cytochrome P450(BM-3)) in Bacillus megaterium by phytochemicals from soy and green tea. J. Agric. Food Chem., 49: 4930-4936.
30. Saddi, G. and F.V. Abbott, 2000. The formalin test in the mouse a parametric analysis of scoring properties. Pain, 89: 53-63.
31. Sawynok, J., M.J. Espey and A. Reid, 1991. 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray. Neuropharmacology, 30: 871-877.
32. Sawynok, J., 1998. Adenosine receptor activation and nociception. Eur. J. Pharmacol., 347: 1-11.
33. Sawynok, J., A. Reid and A. Poon, 1998. Peripheral antinociceptive effect of an adenosine kinase inhibitor with augmentation by an adenosine deaminase inhibitor in the rat formalin test. Pain, 74: 75-81.
34. Sawynok, J. and X.J. Liu, 2003. Adenosine in the spinal cord and periphery release and regulation of pain. Prog. Neurobiol., 69: 313-340.
35. Singh, B., P.M. Sahu and M.K. Sharma, 2002. Anti-inflammatory and antimicrobial activities of triterpenoids from Strobilanthes callosus nees. Phytomedicine, 9: 355-359.
36. Sofowora, A., 1993. Medicinal Plants and Traditional Medicine in Africa. 2nd Edn., Spectrum Books Ltd., Ibadan, Nigeria, ISBN: 978-246-219-5.
37. Szolcsanyi, J., K. Bolcskei, A. Szabo, E. Pinter and G. Petho et al. 2004. Analgesic effect of TT-232 a heptapeptide somatostatin analogue in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia. Eur. J. Pharmacol., 498: 103-109.
38. Tjolsen, A., O. Berge, S. Hunskaar, J.H. Rosland and K. Hole, 1992. The formalin test an evaluation of the method. Pain, 51: 5-17.
39. Trease, G.E. and W.C. Evans, 1989. A Textbook of Pharmacognosy. 13th Edn., Bailliere Tindall Ltd., London, ISBN: 0 7020 1361 7.
40. Vasconcelos, S.M.M., G.R. Oliveira, M.M. De-Carvalho, A.C.P. Rodrigues and E.R. Silveira et al., 2003. Antinociceptive activities of the hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice. Biol. Pharm. Bull., 26: 946-949.
41. Wang, Y.X., S.S. Bowersox, M. Pettus and D. Gao, 1999. Antinociceptive properties of fenfluramine a serotonin reuptake inhibitor in a rat model of neuropathy. J. Pharmacol. Exp. Ther., 291: 1008-1016.
42. Whiteside, G.T., J.M. Boulet and K. Walker, 2005. The role of central and peripheral mu opioid receptors in inflammatory pain and edema a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza- spiro[4.5]dec-3-yl]- acetic acid). J. Pharmacol. Exp. Ther., 314: 1234-1240.
43. Woode, E., E. Boakye-Gyasi, G.K. Ainooson, C. Ansah and M. Duwiejua, 2009. Anti-nociceptive effects and the mechanism of Palisota hirsuta K. Schum. Leaf extract in murine models. Int. J. Pharmacol., 5: 101-113.
44. Yashpal, K. and T.J. Coderre, 1998. Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: Separate mechanisms underlying the nociceptive effects of low-and high-concentration formalin. Eur. J. Pain, 2: 63-68.